Matinas BioPharma
target on tumor cells multiple opportunities in oncology tiple improved therapeutic index efficacy | Matinas BioPharma
Company
Deck Type
Sector
Industry
Deck date
March 2024
Slide
23 of 29
Related slides by other companies
Innoviz
Results
February 2025
opportunities with multiple leading | Innoviz
argenx SE
Investor Presentation
August 2023
opportunity across multiple diseases | argenx SE
Semrush
Investor Day
October 2024
key | Semrush
SentiBio
SPAC
October 2021
senti discovered as a safety antigen that is highly expressed in healthy epithelial cells but not in tumor cells | SentiBio
Other recent decks by Matinas BioPharma
See all presentations (7 decks)
Investor Presentation
February 2024
Investor Presentation
January 2024
Investor Presentation
November 2023
Investor Presentation
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights